Filings & news by date
Hover (PC) or tap (mobile) a candle to see that day only
Kiniksa Pharmaceuticals International, plc
Kiniksa Pharmaceuticals has appointed Ross Moat as President and Chief Operating Officer, effective immediately. Additionally, the company approved an increase in Mr. Moat's annual base salary to $700,000 and his annual target bonus to 60%, effective January 1, 2027.…more
Kiniksa Pharmaceuticals International, plc
Kiniksa Pharmaceuticals insider Mark Ragosa filed a Form 4 report on September 3, 2026, regarding changes in beneficial ownership of securities as of September 1, 2026. This filing serves as an official disclosure of insider equity transactions to the SEC.…more
Kiniksa Pharmaceuticals International, plc
Director Sanj K. Patel of Kiniksa Pharmaceuticals reported a change in beneficial ownership of securities effective September 1, 2026. This filing is a standard Form 4 disclosure regarding insider stock holdings.…more
15 more filings
Sign up free to unlock the full feed and real-time filing & news alerts.
Kiniksa Pharmaceuticals to Report Q3 2026 Financial Results
Kiniksa Pharmaceuticals has scheduled its third quarter 2026 financial results announcement and conference call for October 27, 2026. This is a routine disclosure of an earnings event and is considered neutral for investors.…more
●●●●●●●● ●●●●● ●●●●●●
Kiniksa Pharmaceuticals will participate in a fireside chat at the upcoming 21st Annual Wells Fargo Healthcare Conference on September 9. The presentation will be available for viewing via a live webcast on the company's investor relations website.…more
●●●●●●●● ●●●●● ●●●●●●
키닉사 파마슈티컬스가 오는 8월 12일 카나코드 제뉴이티 연례 성장 컨퍼런스에서 경영진 대담을 진행합니다. 이번 행사를 통해 회사의 사업 전략과 파이프라인에 대한 최신 정보를 투자자들에게 공유할 예정입니다.…more
2 more news items
Sign up free to unlock the full feed and real-time filing & news alerts.